Inventor · disambiguated record
Mark Smith
Also filed as: SMITH MARK · SMITH MARK E · SMITH MARK EDWARD BRENNAN
47 granted patents·27 pending applications·1,342 citations·filing 1999–2024
98Inventor score
Files withRIBOSCIENCE LLC14ILLUMINA CAMBRIDGE LTD13SAVIRA PHARMACEUTICALS GMBH10UNIV LELAND STANFORD JUNIOR9ROCHE PALO ALTO LLC4
Top patents by PatentIndex Score
74 records- 0198US9889422B2Methods of localizing nucleic acids to arraysILLUMINA CAMBRIDGE LTD·Filed 2016·Granted Feb 13, 2018·179 cites·30 claims
- 0298US9388464B2Modified nucleotidesILLUMINA CAMBRIDGE LTD·Filed 2015·Granted Jul 12, 2016·43 cites·11 claims
- 0398US7771973B2Modified nucleotidesILLUMINA CAMBRIDGE LTD·Filed 2009·Granted Aug 10, 2010·100 cites·17 claims
- 0498US7541444B2Modified nucleotidesILLUMINA CAMBRIDGE LTD·Filed 2003·Granted Jun 2, 2009·302 cites·18 claims
- 0598US6846810B2Antiviral nucleoside derivativesROCHE PALO ALTO LLC·Filed 2003·Granted Jan 25, 2005·226 cites·39 claims
- 0697US11654411B2Methods and compositions of localizing nucleic acids to arraysILLUMINA CAMBRIDGE LTD·Filed 2021·Granted May 23, 2023·4 cites·20 claims
- 0797US10953379B2Methods and compositions of localizing nucleic acids to arraysILLUMINA CAMBRIDGE LTD·Filed 2019·Granted Mar 23, 2021·12 cites·20 claims
- 0897US10525437B2Methods and compositions of localizing nucleic acids to arraysILLUMINA CAMBRIDGE LTD·Filed 2018·Granted Jan 7, 2020·11 cites·22 claims
- 0997US8597881B2Modified nucleotidesMILTON JOHN·Filed 2011·Granted Dec 3, 2013·53 cites·15 claims
- 1097US8071739B2Modified nucleotidesMILTON JOHN·Filed 2010·Granted Dec 6, 2011·72 cites·17 claims
- 1196US10513731B2Modified nucleotidesILLUMINA CAMBRIDGE LTD·Filed 2016·Granted Dec 24, 2019·12 cites·11 claims
- 1296US9121060B2Modified nucleotidesILLUMINA CAMBRIDGE LTD·Filed 2013·Granted Sep 1, 2015·48 cites·15 claims
- 1396US8969258B2Methods of localizing nucleic acids to arraysILLUMINA CAMBRIDGE LTD·Filed 2013·Granted Mar 3, 2015·12 cites·17 claims
- 1495US9376710B2Methods of localizing nucleic acids to arraysILLUMINA CAMBRIDGE LTD·Filed 2015·Granted Jun 28, 2016·6 cites·20 claims
- 1595US8563477B2Modified molecular arraysSMITH MARK EDWARD BRENNAN·Filed 2012·Granted Oct 22, 2013·119 cites·31 claims
- 1695US7378402B2Anti-viral nucleosidesROCHE PALO ALTO LLC·Filed 2005·Granted May 27, 2008·39 cites·23 claims
- 1789US9926309B2Pi-kinase inhibitors with anti-infective activityUNIV LELAND STANFORD JUNIOR·Filed 2016·Granted Mar 27, 2018·5 cites·20 claims
- 1888US9370569B24′-difluoromethyl substituted nucleoside derivatives as inhibitors of influenza RNA replicationRIBOSCIENCE LLC·Filed 2015·Granted Jun 21, 2016·8 cites·20 claims
- 1987US9295729B2Reversible covalent linkage of functional moleculesSMITH MARK·Filed 2010·Granted Mar 29, 2016·12 cites·13 claims
- 2086US11091472B2PI-kinase inhibitors with anti-infective activityUNIV LELAND STANFORD JUNIOR·Filed 2017·Granted Aug 17, 2021·3 cites·14 claims
- 2186US9249176B24′-azido, 3′-deoxy-3′-fluoro substituted nucleoside derivatives as inhibitors of HCV RNA replicationRIBOSCIENCE LLC·Filed 2014·Granted Feb 2, 2016·9 cites·20 claims
- 2284US11707471B2ENPP1 inhibitors and their use for the treatment of cancerUNIV LELAND STANFORD JUNIOR·Filed 2022·Granted Jul 25, 2023·1 cites·4 claims
- 2384US10953030B24′-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replicationRIBOSCIENCE LLC·Filed 2019·Granted Mar 23, 2021·1 cites·15 claims
- 2483US11351186B24′-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replicationRIBOSCIENCE LLC·Filed 2020·Granted Jun 7, 2022·1 cites·14 claims
- 2581US10682369B24′-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replicationRIBOSCIENCE LLC·Filed 2018·Granted Jun 16, 2020·1 cites·22 claims
- 2681US10092649B24′-difluoromethyl substituted nucleoside derivatives as inhibitors of influenza RNA replicationRIBOSCIENCE LLC·Filed 2016·Granted Oct 9, 2018·3 cites·19 claims
- 2777US6458851B1Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indicationsSEARLE LLC·Filed 1999·Granted Oct 1, 2002·35 cites·8 claims
- 2875US10933142B2Reversible covalent linkage of functional moleculesUCL BUSINESS LTD·Filed 2019·Granted Mar 2, 2021·0 cites·7 claims
- 2975US2020399692A1Modified nucleotidesILLUMINA CAMBRIDGE LTD·Filed 2020·Application pending·0 cites
- 3074US2020017908A1Modified nucleotidesILLUMINA CAMBRIDGE LTD·Filed 2019·Application pending·0 cites
- 3173US9895442B24′-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replicationRIBOSCIENCE LLC·Filed 2014·Granted Feb 20, 2018·2 cites·24 claims
- 3273US7625897B2Non-nucleoside reverse transcriptase inhibitorsROCHE PALO ALTO LLC·Filed 2006·Granted Dec 1, 2009·2 cites·14 claims
- 3372US2025059218A1ENPP1 Inhibitors and Methods of Modulating Immune ResponseUNIV LELAND STANFORD JUNIOR·Filed 2024·Application pending·0 cites
- 3470US8921388B2Dihydroxypyrimidine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral diseaseSAVIRA PHARMACEUTICALS GMBH·Filed 2013·Granted Dec 30, 2014·2 cites·28 claims
- 3569US11884657B2PI-kinase inhibitors with anti-infective activityUNIV LELAND STANFORD JUNIOR·Filed 2021·Granted Jan 30, 2024·0 cites·20 claims
- 3669US2023277570A1ENPP1 Inhibitors and Their Use for the Treatment of CancerUNIV LELAND STANFORD JUNIOR·Filed 2023·Application pending·0 cites
- 3768US2007203246A1Combinations of Cholesterol Ester Transfer Protein Inhibitors and HMG COA Reductase Inhibitors for Cardiovascular IndicationsPFIZER·Filed 2007·Application pending·0 cites
- 3867US2021369755A14'-Fluoro-2'-Methyl Substituted Nucleoside Derivatives as Inhibitors of HCV RNA ReplicationRIBOSCIENCE LLC·Filed 2021·Application pending·0 cites
- 3964US6462091B1Combinations of cholesteryl ester transfer protein inhibitors and HMG coA reductase inhibitors for cardiovascular indicationsSEARLE & CO·Filed 1999·Granted Oct 8, 2002·15 cites·11 claims
- 4063US10548982B2Reversible covalent linkage of functional moleculesUCL BUSINESS PLC·Filed 2018·Granted Feb 4, 2020·0 cites·10 claims
- 4163US9434745B27-oxo-thiazolopyridine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral diseaseSAVIRA PHARMACEUTICALS GMBH·Filed 2013·Granted Sep 6, 2016·1 cites·14 claims
- 4262US9199987B2Substituted naphthyridines for the treatment, amelioration or prevention of a viral diseaseSAVIRA PHARMACEUTICALS GMBH·Filed 2014·Granted Dec 1, 2015·0 cites·8 claims
- 4362US2018200280A14'-Fluoro-2'-Methyl Substituted Nucleoside Derivatives as Inhibitors of HCV RNA ReplicationRIBOSCIENCE LLC·Filed 2017·Application pending·0 cites
- 4461US11701371B2ENPP1 inhibitors and their use for the treatment of cancerUNIV LELAND STANFORD JUNIOR·Filed 2018·Granted Jul 18, 2023·0 cites·7 claims
- 4560US2011059865A1Modified Molecular ArraysSMITH MARK EDWARD BRENNAN·Filed 2005·Application pending·0 cites
- 4659US2003166712A1Combinations of cholesteryl ester transfer protein inhibitors and HMG CoA reductase inhibitors for cardiovascular indicationsSEARLE & CO·Filed 2002·Application pending·0 cites
- 4758US9505758B2Substituted 1,5-naphthyridines as endonuclease inhibitorsSAVIRA PHARMACEUTICALS GMBH·Filed 2015·Granted Nov 29, 2016·0 cites·5 claims
- 4856US10174094B2Reversible covalent linkage of functional moleculesUCL BUSINESS PLC·Filed 2016·Granted Jan 8, 2019·0 cites·5 claims
- 4955US2017290834A1Naphthyridinone derivatives and their use in the treatment, amelioration or prevention of a viral diseaseSAVIRA PHARMACEUTICALS GMBH·Filed 2016·Application pending·0 cites
- 5053US6593489B1Substituted cyclopentenes, their preparation and their use for chiral scaffoldsCHIROTECHTECHNOLOGY LTD·Filed 2000·Granted Jul 15, 2003·3 cites·31 claims
Showing the top 50 of 74 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Mark Smith files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →